amantadine has been researched along with Apoplexy in 9 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Excerpt | Relevance | Reference |
---|---|---|
"To assess the efficacy and safety of amantadine sulfate in patients with ischemic stroke." | 9.34 | [The use of amantadine sulfate in ischemic stroke]. ( Akhmatkhanova, LK; Kovaleva, EA; Ramazanov, GR; Shevchenko, EV, 2020) |
"Amantadine and modafinil are neurostimulants that may improve cognitive and functional recovery post-stroke, but the existing study results vary, and no comprehensive review has been published." | 9.05 | Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review. ( Brown, CS; Cote, J; Eldridge, A; Gagnon, DJ; Leclerc, AM; May, T; Nocella, K; Riker, RR; Seder, DB, 2020) |
"To assess the efficacy and safety of amantadine sulfate in patients with ischemic stroke." | 5.34 | [The use of amantadine sulfate in ischemic stroke]. ( Akhmatkhanova, LK; Kovaleva, EA; Ramazanov, GR; Shevchenko, EV, 2020) |
"Amantadine and modafinil are neurostimulants that may improve cognitive and functional recovery post-stroke, but the existing study results vary, and no comprehensive review has been published." | 5.05 | Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review. ( Brown, CS; Cote, J; Eldridge, A; Gagnon, DJ; Leclerc, AM; May, T; Nocella, K; Riker, RR; Seder, DB, 2020) |
"We pooled individual patient data of five single-centre observational studies to determine the effect of amantadine treatment among patients with ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, community-acquired bacterial meningitis and status epilepticus, admitted between January 2012 and December 2015 and ventilated ≥7 days." | 4.12 | Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury. ( Balk, S; Gerner, ST; Giede-Jeppe, A; Huttner, HB; Jäger, J; Kallmünzer, B; Kuramatsu, JB; Madzar, D; Mueller, T; Rühl, L; Schwab, S; Sembill, JA; Sprügel, MI, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Rühl, L | 1 |
Kuramatsu, JB | 1 |
Sembill, JA | 1 |
Kallmünzer, B | 1 |
Madzar, D | 1 |
Gerner, ST | 1 |
Giede-Jeppe, A | 1 |
Balk, S | 1 |
Mueller, T | 1 |
Jäger, J | 1 |
Schwab, S | 1 |
Huttner, HB | 1 |
Sprügel, MI | 1 |
Gagnon, DJ | 2 |
Leclerc, AM | 2 |
Riker, RR | 2 |
Brown, CS | 2 |
May, T | 2 |
Nocella, K | 2 |
Cote, J | 2 |
Eldridge, A | 2 |
Seder, DB | 2 |
Ramazanov, GR | 1 |
Kovaleva, EA | 1 |
Shevchenko, EV | 1 |
Akhmatkhanova, LK | 1 |
Wilcox, SK | 1 |
Garry, A | 1 |
Johnson, MJ | 1 |
Krivonos, OV | 1 |
Amosova, NA | 1 |
Smolentseva, IG | 1 |
Barrett, AM | 1 |
Levy, CE | 1 |
Gonzalez Rothi, LJ | 1 |
Kazui, H | 1 |
Mori, E | 1 |
Hashimoto, M | 1 |
Hirono, N | 1 |
Satou, T | 1 |
Wada, H | 1 |
Arai, H | 1 |
Sasaki, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Amantadine for Neuroenhancement in Acute Patients Study - A Prospective Pilot Proof of Concept Phase IIb Study in Intensive and Intermediate Care Unit Patients[NCT05479032] | Phase 2 | 50 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for amantadine and Apoplexy
Article | Year |
---|---|
Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.
Topics: Amantadine; Central Nervous System Stimulants; Dopamine Agents; Humans; Modafinil; Recovery of Funct | 2020 |
2 trials available for amantadine and Apoplexy
Article | Year |
---|---|
[The use of amantadine sulfate in ischemic stroke].
Topics: Amantadine; Brain Ischemia; Humans; Ischemic Stroke; Russia; Stroke; Treatment Outcome | 2020 |
Use of the glutamate NMDA receptor antagonist PK-Merz in acute stroke.
Topics: Amantadine; Female; Humans; Male; Middle Aged; Receptors, N-Methyl-D-Aspartate; Stroke | 2010 |
6 other studies available for amantadine and Apoplexy
Article | Year |
---|---|
Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury.
Topics: Amantadine; Brain Injuries; Brain Ischemia; Consciousness; Delirium; Glasgow Coma Scale; Humans; Sei | 2022 |
Amantadine and Modafinil as Neurostimulants Following Acute Stroke: A Retrospective Study of Intensive Care Unit Patients.
Topics: Adult; Amantadine; Central Nervous System Stimulants; Humans; Intensive Care Units; Modafinil; Retro | 2021 |
Novel use of amantadine: to treat hiccups.
Topics: Aged; Amantadine; Analgesics, Non-Narcotic; Antidepressive Agents; Fatal Outcome; Hiccup; Humans; Ma | 2009 |
Pharmaceuticals for poststroke and brain injury rehabilitation.
Topics: Amantadine; Aphasia, Broca; Brain Injuries; Dopamine Agents; Humans; Methylphenidate; Persistent Veg | 2007 |
Phobia after bilateral thalamic hemorrhage.
Topics: Amantadine; Cerebral Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phobic Disor | 2001 |
[The prevention of pneumonia in the elderly by dopamine agonists].
Topics: Aged; Amantadine; Angiotensin-Converting Enzyme Inhibitors; Dopamine Agonists; Humans; Levodopa; Pne | 2001 |